✦ LIBER ✦

Incentives for Research, Development, and Innovation in Pharmaceuticals || Incentives for innovation: Neglected diseases

✍ Scribed by García-Fontes, Walter

Book ID: 120294799
Publisher: Springer Healthcare Iberica
Year: 2011
Weight: 272 KB
Category: Article
ISBN: 8493806277
DOI: 10.1007/978-84-938062-7-9_3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Creating alternative incentives for phar

Creating alternative incentives for pharmaceutical innovation

✍ Alan Lyles 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 247 KB

US industrial research: Incentives for i

US industrial research: Incentives for innovation

✍ David, Peter 📂 Article 📅 1983 🏛 Nature Publishing Group 🌐 English ⚖ 132 KB

Incentives for research on neglected dis

Incentives for research on neglected disease

✍ Michael Kremer; Rachel Glennerster 📂 Article 📅 2005 🏛 The Lancet 🌐 English ⚖ 41 KB

Incentives for Innovation: Patents, Priz

Incentives for Innovation: Patents, Prizes, and Research Contracts

✍ Clancy, M. S.; Moschini, G. 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 727 KB

Managerial incentives for process innova

Managerial incentives for process innovation

✍ Bastiaan M. Overvest; Jasper Veldman 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 116 KB

## Abstract Cost‐reducing investments by firms are often not publicly observable. This lack of observability would preclude a strategic use of process innovation. However, we show that an observable and verifiable contract that provides direct monetary incentives for cost reductions — an innovation

Union structure and incentives for innov

Union structure and incentives for innovation

✍ Vicente Calabuig; Miguel Gonzalez-Maestre 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 151 KB